Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
WHO AMR Survivor Task Force: Fireside Chat
Dear All, Back in 2022, I wrote a newsletter about the World Health Organization putting out a call to form
Read More >
G20 Health Ministers: Let\’s take action on AMR!
Dear All, As we\’ve discussed previously (1 Oct 2024 newsletter), the HLM on AMR at UNGA 2024 is but one
Read More >
BARDA seeks deep insight on antibacterials near/beyond end-of-Phase 2
Dear All, BARDA has released a fascinating Sources Sought Notice (SSN) seeking data on antibacterials near, at, or beyond Phase 2.
Read More >
NIAID RFA: Centers for Accelerating Phage Therapy (CAPT-CEP)
Dear All, I was delighted to learn today that NIAID has released RFA-AI-24-069, a notice of funding opportunity (NOFO) soliciting applications
Read More >
Vivli: Access to Industry’s Susceptibility Surveillance data
Dear All (and with thanks to Patricia Bradford for leading on this newsletter), Did you know you can access raw
Read More >
Italy funds CARB-X and announces pull incentive!
Dear All (and with thanks to Damiano for co-authoring), We have exciting news from the G7 Health Ministers’ Meeting, which was
Read More >
Plazomicin (Achaogen) financial post-mortem: #PassPASTEUR
Dear All (and with thanks to Kevin for co-authoring and also a wonkish alert … get your coffee and settle
Read More >
EPA (part 5): Interagency Framework on AMR Risks of Antibacterial and Antifungal Pesticides
This is the fifth of a 5-part newsletter series. There is an initial 27 Sep 2023 newsletter introducing the EPA concept note, a second (28
Read More >
HLM on AMR at UNGA: The end of the beginning
Aside: Please refer to our UNGA 2024 webpage for additional post-HLM notes and updates. 28 Oct 2024 addendum and another way
Read More >
Without action, AMR costs go from $66b to $159b/yr by 2050
Dear All, A new paper from Anthony McDonnell and a team led by the Center for Global Development extends estimates
Read More >
UN TV: You can watch the AMR High-Level Meeting at UNGA
Dear All, The AMR HLM (High-Level Meeting) at the UN General Assembly starts at 10a ET today. You can watch
Read More >
PACE: A £5m funding round for diagnostics
Dear All, The peri-UNGA week is generating a lot of activity! Having about a year ago launched a £30m fund
Read More >
26 Sep 2024 is a day of virtual advocacy: #PassPASTEUR
Dear All, I have just learned that in parallel with the 26 Sep 2024 High-Level Meeting on AMR at the
Read More >
New CARB-X round with expanded TPPs (enteric infection, S. aureus, E. coli)
Dear All, CARB-X have opened their 2nd funding round for 2024! The Expression of Interest (EoI) deadline is 4 Oct
Read More >
AMR High-Level Meeting Draft Declaration / Australia and Canada engage on Pull models!
Dear All, Greetings from Porto (Portugal) where we’ve just ended the 2024 edition of the ESCMID-ASM Developer’s Meeting .. a superb
Read More >
#AMRSOS! AMR could worsen, killing 39m during 2025-2050
Dear All, Just in time for the United Nations General Assembly High-Level Meeting on AMR, the team behind the global
Read More >
Lifeline, the Musical Story of Penicillin: A Review
Dear All, Last week I went to New York City to see one of the opening performances of Lifeline, The Musical, the
Read More >
WHO: AMR Policy Brief and Preclinical pipeline data call
Dear All, Supplementing and augmenting their review of the clinical and preclinical pipeline through 31 Dec 2023 (see the 15
Read More >
UK Subscription model goes live! Value bands cover entire UK!
Dear All (with thanks to Kevin for leading on this newsletter and with a wonkish / long-read alert on this
Read More >
Needles and haystacks: Preclinical antibacterial pipeline review
Dear All, Just published in AAC is WHO’s updated review of the global preclinical pipeline. Here are the links you
Read More >